Sinopharm Group Balance Sheet Health
Financial Health criteria checks 5/6
Sinopharm Group has a total shareholder equity of CN¥122.4B and total debt of CN¥95.6B, which brings its debt-to-equity ratio to 78.1%. Its total assets and total liabilities are CN¥429.6B and CN¥307.2B respectively. Sinopharm Group's EBIT is CN¥20.9B making its interest coverage ratio 11.4. It has cash and short-term investments of CN¥43.3B.
Key information
78.1%
Debt to equity ratio
CN¥95.61b
Debt
| Interest coverage ratio | 11.4x |
| Cash | CN¥43.33b |
| Equity | CN¥122.43b |
| Total liabilities | CN¥307.15b |
| Total assets | CN¥429.58b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1099's short term assets (CN¥382.4B) exceed its short term liabilities (CN¥283.2B).
Long Term Liabilities: 1099's short term assets (CN¥382.4B) exceed its long term liabilities (CN¥23.9B).
Debt to Equity History and Analysis
Debt Level: 1099's net debt to equity ratio (42.7%) is considered high.
Reducing Debt: 1099's debt to equity ratio has reduced from 97.2% to 78.1% over the past 5 years.
Debt Coverage: 1099's debt is well covered by operating cash flow (20.4%).
Interest Coverage: 1099's interest payments on its debt are well covered by EBIT (11.4x coverage).